Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/20/24 16:06 | 10/30/23 | DCPH | Health | Drug | Pharmaceutical Preparations | Sherman Matthew L | MA | O | EVP,Chie | 7 | S.d | -223 | 14.15 | 0 | -16 | 109 | D | |||||||||||||||
2/20/24 16:05 | 10/30/23 | DCPH | Health | Drug | Pharmaceutical Preparations | Kelly Thomas Patrick | MA | O | CFO | 6 | S.d | -198 | 14.55 | 0 | -14 | 80 | D | |||||||||||||||
2/20/24 16:05 | 10/30/23 | DCPH | Health | Drug | Pharmaceutical Preparations | Pitman Jama | MA | O | SVP,Chie | 6 | S.d | -137 | 14.61 | 0 | -9 | 68 | D | |||||||||||||||
2/20/24 16:05 | 10/30/23 | DCPH | Health | Drug | Pharmaceutical Preparations | Martin Daniel C. | MA | O | Chief Co | 7 | S.d | -361 | 13.28 | 0 | -27 | 63 | D | |||||||||||||||
12/14/23 16:05 | 10/30/23 | DCPH | Health | Drug | Pharmaceutical Preparations | Hoerter Steven L. | MA | DO | P,CEO | 4 | S.d | -1,328 | 14.79 | 0 | -90 | 73 | D | |||||||||||||||
6/21/23 16:05 | 6/16/23 | DCPH | Health | Drug | Pharmaceutical Preparations | Flynn Daniel Lee | MA | O | Chief Sc | 2 | S.d | -45 | 14.72 | 0 | -3 | 380 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |